GB-0895

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameGB-0895

Drug Alias NameGB-0895

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionThymic stromal lymphopoietin inhibitors

TargetsThymic stromal lymphopoietin

Therapy Area/IndicationsImmune System DiseasesPulmonary Disease, Chronic ObstructiveAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermanyUnited Kingdom +[4]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Inactive IndicationsImmune System Diseases

ATC CodeN/A